Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 26 entries
Sorted by: Best Match Show Resources per page
Therapy for stable angina in women.

P & T : a peer-reviewed journal for formulary management

Sarbaziha R, Sedlak T, Shufelt C, Mehta PK, Merz CN.
PMID: 22876105
P T. 2012 Jul;37(7):400-4.

Mortality rates for cardiovascular disease are higher in women than in men, but studies of women have been conducted less frequently. Current pharmacological and nonpharmacological treatment options for women with stable angina are reviewed.

Cite
Sarbaziha R, Sedlak T, Shufelt C, et al. Therapy for stable angina in women. P T. 2012;37(7):400-4
Sarbaziha, R., Sedlak, T., Shufelt, C., Mehta, P. K., & Merz, C. N. (2012). Therapy for stable angina in women. P & T : a peer-reviewed journal for formulary management, 37(7), 400-4.
Sarbaziha, Raheleh, et al. "Therapy for stable angina in women." P & T : a peer-reviewed journal for formulary management vol. 37,7 (2012): 400-4.
Sarbaziha R, Sedlak T, Shufelt C, Mehta PK, Merz CN. Therapy for stable angina in women. P T. 2012 Jul;37(7):400-4. PMID: 22876105; PMCID: PMC3411210.
Copy Download .nbib Format: NLM
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Cardiovascular diagnosis and therapy

Nicholls SJ, Tuzcu EM, Wolski K, Johnson BD, Sopko G, Sharaf BL, Pepine CJ, Nissen SE, Bairey Merz CN.
PMID: 30214855
Cardiovasc Diagn Ther. 2018 Aug;8(4):405-413. doi: 10.21037/cdt.2018.04.03.

BACKGROUND: Information regarding the pathogenesis of ischemic heart disease (IHD) in women is limited. Sex-specific responses to atherosclerosis and coronary arterial remodelling in women versus men have been hypothesized, but limited study exists.METHODS: Case-matched study of 174 women with...

Cite
Nicholls SJ, Tuzcu EM, Wolski K, et al. Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Cardiovasc Diagn Ther. 2018;8(4):405-413doi: 10.21037/cdt.2018.04.03.
Nicholls, S. J., Tuzcu, E. M., Wolski, K., Johnson, B. D., Sopko, G., Sharaf, B. L., Pepine, C. J., Nissen, S. E., & Bairey Merz, C. N. (2018). Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Cardiovascular diagnosis and therapy, 8(4), 405-413. https://doi.org/10.21037/cdt.2018.04.03
Nicholls, Stephen J, et al. "Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation." Cardiovascular diagnosis and therapy vol. 8,4 (2018): 405-413. doi: https://doi.org/10.21037/cdt.2018.04.03
Nicholls SJ, Tuzcu EM, Wolski K, Johnson BD, Sopko G, Sharaf BL, Pepine CJ, Nissen SE, Bairey Merz CN. Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Cardiovasc Diagn Ther. 2018 Aug;8(4):405-413. doi: 10.21037/cdt.2018.04.03. PMID: 30214855; PMCID: PMC6129832.
Copy Download .nbib Format: NLM
Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus.

JAMA cardiology

Quesada O, Shufelt C, Bairey Merz CN.
PMID: 32936208
JAMA Cardiol. 2020 Dec 01;5(12):1398-1400. doi: 10.1001/jamacardio.2020.4117.

No abstract available.

Cite
Quesada O, Shufelt C, Bairey Merz CN. Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA Cardiol. 2020;5(12):1398-1400doi: 10.1001/jamacardio.2020.4117.
Quesada, O., Shufelt, C., & Bairey Merz, C. N. (2020). Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA cardiology, 5(12), 1398-1400. https://doi.org/10.1001/jamacardio.2020.4117
Quesada, Odayme, et al. "Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus." JAMA cardiology vol. 5,12 (2020): 1398-1400. doi: https://doi.org/10.1001/jamacardio.2020.4117
Quesada O, Shufelt C, Bairey Merz CN. Can We Improve Cardiovascular Disease for Women Using Data Under Our Noses?: A Need for Changes in Policy and Focus. JAMA Cardiol. 2020 Dec 01;5(12):1398-1400. doi: 10.1001/jamacardio.2020.4117. PMID: 32936208; PMCID: PMC8074640.
Copy Download .nbib Format: NLM
Calcium Supplements and Cardiovascular Disease: A Review.

American journal of lifestyle medicine

Waldman T, Sarbaziha R, Merz CN, Shufelt C.
PMID: 26345134
Am J Lifestyle Med. 2015 Jul 01;9(4):298-307. doi: 10.1177/1559827613512593.

Dietary or supplemental calcium intake has long been encouraged for optimal bone health. However, more recently, the safety of calcium supplementation has been questioned because of a possible association between supplemental calcium and cardiovascular risk. Whereas calcium may have...

Cite
Waldman T, Sarbaziha R, Merz CN, et al. Calcium Supplements and Cardiovascular Disease: A Review. Am J Lifestyle Med. 2015;9(4):298-307doi: 10.1177/1559827613512593.
Waldman, T., Sarbaziha, R., Merz, C. N., & Shufelt, C. (2015). Calcium Supplements and Cardiovascular Disease: A Review. American journal of lifestyle medicine, 9(4), 298-307. https://doi.org/10.1177/1559827613512593
Waldman, Talya, et al. "Calcium Supplements and Cardiovascular Disease: A Review." American journal of lifestyle medicine vol. 9,4 (2015): 298-307. doi: https://doi.org/10.1177/1559827613512593
Waldman T, Sarbaziha R, Merz CN, Shufelt C. Calcium Supplements and Cardiovascular Disease: A Review. Am J Lifestyle Med. 2015 Jul 01;9(4):298-307. doi: 10.1177/1559827613512593. PMID: 26345134; PMCID: PMC4560115.
Copy Download .nbib Format: NLM
Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.

Cardiovascular diagnosis and therapy

Bakir M, Wei J, Nelson MD, Mehta PK, Haftbaradaran A, Jones E, Gill E, Sharif B, Slomka PJ, Li D, Shufelt CL, Minissian M, Berman DS, Bairey Merz CN, Thomson LE.
PMID: 26885495
Cardiovasc Diagn Ther. 2016 Feb;6(1):78-86. doi: 10.3978/j.issn.2223-3652.2015.09.03.

Angina, heart failure with preserved ejection fraction (HFpEF) and coronary microvascular dysfunction (CMD) in the absence of obstructive coronary artery disease (CAD) are more common in women and are associated with adverse cardiovascular prognosis. Cardiac magnetic resonance imaging (CMRI)...

Cite
Bakir M, Wei J, Nelson MD, et al. Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women. Cardiovasc Diagn Ther. 2016;6(1):78-86doi: 10.3978/j.issn.2223-3652.2015.09.03.
Bakir, M., Wei, J., Nelson, M. D., Mehta, P. K., Haftbaradaran, A., Jones, E., Gill, E., Sharif, B., Slomka, P. J., Li, D., Shufelt, C. L., Minissian, M., Berman, D. S., Bairey Merz, C. N., & Thomson, L. E. (2016). Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women. Cardiovascular diagnosis and therapy, 6(1), 78-86. https://doi.org/10.3978/j.issn.2223-3652.2015.09.03
Bakir, May, et al. "Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women." Cardiovascular diagnosis and therapy vol. 6,1 (2016): 78-86. doi: https://doi.org/10.3978/j.issn.2223-3652.2015.09.03
Bakir M, Wei J, Nelson MD, Mehta PK, Haftbaradaran A, Jones E, Gill E, Sharif B, Slomka PJ, Li D, Shufelt CL, Minissian M, Berman DS, Bairey Merz CN, Thomson LE. Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women. Cardiovasc Diagn Ther. 2016 Feb;6(1):78-86. doi: 10.3978/j.issn.2223-3652.2015.09.03. PMID: 26885495; PMCID: PMC4731584.
Copy Download .nbib Format: NLM
Treatment of angina and microvascular coronary dysfunction.

Current treatment options in cardiovascular medicine

Samim A, Nugent L, Mehta PK, Shufelt C, Bairey Merz CN.
PMID: 20842559
Curr Treat Options Cardiovasc Med. 2010 Aug;12(4):355-64. doi: 10.1007/s11936-010-0083-8.

OPINION STATEMENT: Microvascular coronary dysfunction (MCD) is an increasingly recognized cause of cardiac ischemia and angina that is diagnosed more commonly in women. Patients with MCD present with the triad of persistent chest pain, ischemic changes on stress testing,...

Cite
Samim A, Nugent L, Mehta PK, et al. Treatment of angina and microvascular coronary dysfunction. Curr Treat Options Cardiovasc Med. 2010;12(4):355-64doi: 10.1007/s11936-010-0083-8.
Samim, A., Nugent, L., Mehta, P. K., Shufelt, C., & Bairey Merz, C. N. (2010). Treatment of angina and microvascular coronary dysfunction. Current treatment options in cardiovascular medicine, 12(4), 355-64. https://doi.org/10.1007/s11936-010-0083-8
Samim, Arang, et al. "Treatment of angina and microvascular coronary dysfunction." Current treatment options in cardiovascular medicine vol. 12,4 (2010): 355-64. doi: https://doi.org/10.1007/s11936-010-0083-8
Samim A, Nugent L, Mehta PK, Shufelt C, Bairey Merz CN. Treatment of angina and microvascular coronary dysfunction. Curr Treat Options Cardiovasc Med. 2010 Aug;12(4):355-64. doi: 10.1007/s11936-010-0083-8. PMID: 20842559; PMCID: PMC3914311.
Copy Download .nbib Format: NLM
Challenging Statin Pleiotropy: Preeclampsia.

Circulation

Wei J, Liao JK, Bairey Merz CN.
PMID: 34460319
Circulation. 2021 Aug 31;144(9):680-683. doi: 10.1161/CIRCULATIONAHA.121.056140. Epub 2021 Aug 30.

No abstract available.

Cite
Wei J, Liao JK, Bairey Merz CN. Challenging Statin Pleiotropy: Preeclampsia. Circulation. 2021;144(9):680-683doi: 10.1161/CIRCULATIONAHA.121.056140.
Wei, J., Liao, J. K., & Bairey Merz, C. N. (2021). Challenging Statin Pleiotropy: Preeclampsia. Circulation, 144(9), 680-683. https://doi.org/10.1161/CIRCULATIONAHA.121.056140
Wei, Janet, et al. "Challenging Statin Pleiotropy: Preeclampsia." Circulation vol. 144,9 (2021): 680-683. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056140
Wei J, Liao JK, Bairey Merz CN. Challenging Statin Pleiotropy: Preeclampsia. Circulation. 2021 Aug 31;144(9):680-683. doi: 10.1161/CIRCULATIONAHA.121.056140. Epub 2021 Aug 30. PMID: 34460319; PMCID: PMC8437106.
Copy Download .nbib Format: NLM
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists.

Biology of sex differences

Ouyang P, Wenger NK, Taylor D, Rich-Edwards JW, Steiner M, Shaw LJ, Berga SL, Miller VM, Merz NB.
PMID: 27034774
Biol Sex Differ. 2016 Mar 31;7:19. doi: 10.1186/s13293-016-0073-y. eCollection 2016.

BACKGROUND: In 2001, the Institute of Medicine's (IOM) report, "Exploring the Biological Contributions to Human Health: Does Sex Matter?" advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical...

Cite
Ouyang P, Wenger NK, Taylor D, et al. Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biol Sex Differ. 2016;7:19doi: 10.1186/s13293-016-0073-y.
Ouyang, P., Wenger, N. K., Taylor, D., Rich-Edwards, J. W., Steiner, M., Shaw, L. J., Berga, S. L., Miller, V. M., & Merz, N. B. (2016). Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biology of sex differences, 719. https://doi.org/10.1186/s13293-016-0073-y
Ouyang, Pamela, et al. "Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists." Biology of sex differences vol. 7 (2016): 19. doi: https://doi.org/10.1186/s13293-016-0073-y
Ouyang P, Wenger NK, Taylor D, Rich-Edwards JW, Steiner M, Shaw LJ, Berga SL, Miller VM, Merz NB. Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biol Sex Differ. 2016 Mar 31;7:19. doi: 10.1186/s13293-016-0073-y. eCollection 2016. PMID: 27034774; PMCID: PMC4815158.
Copy Download .nbib Format: NLM
Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software.

Cardiovascular diagnosis and therapy

Goykhman P, Mehta PK, Agarwal M, Shufelt C, Slomka PJ, Yang Y, Xu Y, Shaw LJ, Berman DS, Merz NB, Thomson LE.
PMID: 24282727
Cardiovasc Diagn Ther. 2012 Dec;2(4):268-77. doi: 10.3978/j.issn.2223-3652.2012.10.02.

PURPOSE: Adenosine stress first pass cardiac magnetic resonance imaging (CMRI) is a rapidly evolving tool in the diagnosis of ischemic heart disease (IHD). The rest and stress first pass myocardial perfusion data may be interpreted using commercially available software...

Cite
Goykhman P, Mehta PK, Agarwal M, et al. Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovasc Diagn Ther. 2012;2(4):268-77doi: 10.3978/j.issn.2223-3652.2012.10.02.
Goykhman, P., Mehta, P. K., Agarwal, M., Shufelt, C., Slomka, P. J., Yang, Y., Xu, Y., Shaw, L. J., Berman, D. S., Merz, N. B., & Thomson, L. E. (2012). Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovascular diagnosis and therapy, 2(4), 268-77. https://doi.org/10.3978/j.issn.2223-3652.2012.10.02
Goykhman, Pavel, et al. "Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software." Cardiovascular diagnosis and therapy vol. 2,4 (2012): 268-77. doi: https://doi.org/10.3978/j.issn.2223-3652.2012.10.02
Goykhman P, Mehta PK, Agarwal M, Shufelt C, Slomka PJ, Yang Y, Xu Y, Shaw LJ, Berman DS, Merz NB, Thomson LE. Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovasc Diagn Ther. 2012 Dec;2(4):268-77. doi: 10.3978/j.issn.2223-3652.2012.10.02. PMID: 24282727; PMCID: PMC3839165.
Copy Download .nbib Format: NLM
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

Cardiovascular diagnosis and therapy

Doyle M, Weinberg N, Pohost GM, Merz CN, Shaw LJ, Sopko G, Fuisz A, Rogers WJ, Walsh EG, Johnson BD, Sharaf BL, Pepine CJ, Mankad S, Reis SE, Rayarao G, Vido DA, Bittner V, Tauxe L, Olson MB, Kelsey SF, Biederman RW.
PMID: 24015377
Cardiovasc Diagn Ther. 2013 Jun;3(2):64-72. doi: 10.3978/j.issn.2223-3652.2013.05.02.

OBJECTIVES: To assess the prognostic value of a left ventricular energy-model in women with suspected myocardial ischemia.BACKGROUND: The prognostic value of internal energy utilization (IEU) of the left ventricle in women with suspected myocardial ischemia is unknown.METHODS: Women (n=227,...

Cite
Doyle M, Weinberg N, Pohost GM, et al. Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Cardiovasc Diagn Ther. 2013;3(2):64-72doi: 10.3978/j.issn.2223-3652.2013.05.02.
Doyle, M., Weinberg, N., Pohost, G. M., Merz, C. N., Shaw, L. J., Sopko, G., Fuisz, A., Rogers, W. J., Walsh, E. G., Johnson, B. D., Sharaf, B. L., Pepine, C. J., Mankad, S., Reis, S. E., Rayarao, G., Vido, D. A., Bittner, V., Tauxe, L., Olson, M. B., Kelsey, S. F., & Biederman, R. W. (2013). Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Cardiovascular diagnosis and therapy, 3(2), 64-72. https://doi.org/10.3978/j.issn.2223-3652.2013.05.02
Doyle, Mark, et al. "Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study." Cardiovascular diagnosis and therapy vol. 3,2 (2013): 64-72. doi: https://doi.org/10.3978/j.issn.2223-3652.2013.05.02
Doyle M, Weinberg N, Pohost GM, Merz CN, Shaw LJ, Sopko G, Fuisz A, Rogers WJ, Walsh EG, Johnson BD, Sharaf BL, Pepine CJ, Mankad S, Reis SE, Rayarao G, Vido DA, Bittner V, Tauxe L, Olson MB, Kelsey SF, Biederman RW. Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Cardiovasc Diagn Ther. 2013 Jun;3(2):64-72. doi: 10.3978/j.issn.2223-3652.2013.05.02. PMID: 24015377; PMCID: PMC3763744.
Copy Download .nbib Format: NLM
Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease.

Current trends in clinical & medical imaging

Al-Badri A, Wei J, Landes S, Motwani M, Cook-Wiens G, Nelson MD, Mehta PK, Shufelt C, Sharif B, Li D, Berman DS, Thomson LE, Merz CNB.
PMID: 30976755
Curr Trends Clin Med Imaging. 2018;2(3). doi: 10.19080/CTCMI.2018.02.555587. Epub 2018 Feb 23.

BACKGROUND: Cardiovascular magnetic resonance imaging (CMRI) derived myocardial perfusion reserve index (MPRI) has recently been shown to detect coronary microvascular dysfunction (CMD) in women with signs and symptoms of ischemia and no obstructive coronary artery disease (CAD). The aim...

Cite
Al-Badri A, Wei J, Landes S, et al. Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Curr Trends Clin Med Imaging. 2018;2(3)doi: 10.19080/CTCMI.2018.02.555587.
Al-Badri, A., Wei, J., Landes, S., Motwani, M., Cook-Wiens, G., Nelson, M. D., Mehta, P. K., Shufelt, C., Sharif, B., Li, D., Berman, D. S., Thomson, L. E., & Merz, C. N. B. (2018). Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Current trends in clinical & medical imaging, 2(3), . https://doi.org/10.19080/CTCMI.2018.02.555587
Al-Badri, Ahmed, et al. "Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease." Current trends in clinical & medical imaging vol. 2,3 (2018). doi: https://doi.org/10.19080/CTCMI.2018.02.555587
Al-Badri A, Wei J, Landes S, Motwani M, Cook-Wiens G, Nelson MD, Mehta PK, Shufelt C, Sharif B, Li D, Berman DS, Thomson LE, Merz CNB. Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease. Curr Trends Clin Med Imaging. 2018;2(3). doi: 10.19080/CTCMI.2018.02.555587. Epub 2018 Feb 23. PMID: 30976755; PMCID: PMC6455951.
Copy Download .nbib Format: NLM
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).

Cardiovascular diagnosis and therapy

Doyle M, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, Rogers WJ, Sharaf BL, Pepine CJ, Thompson DV, Rayarao G, Tauxe L, Kelsey SF, Biederman RW.
PMID: 27747165
Cardiovasc Diagn Ther. 2016 Oct;6(5):424-431. doi: 10.21037/cdt.2016.03.11.

BACKGROUND: We introduce an algorithmic approach to optimize diagnostic and prognostic value of gated cardiac single photon emission computed tomography (SPECT) and magnetic resonance (MR) myocardial perfusion imaging (MPI) modalities in women with suspected myocardial ischemia. The novel approach:...

Cite
Doyle M, Pohost GM, Bairey Merz CN, et al. Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). Cardiovasc Diagn Ther. 2016;6(5):424-431doi: 10.21037/cdt.2016.03.11.
Doyle, M., Pohost, G. M., Bairey Merz, C. N., Shaw, L. J., Sopko, G., Rogers, W. J., Sharaf, B. L., Pepine, C. J., Thompson, D. V., Rayarao, G., Tauxe, L., Kelsey, S. F., & Biederman, R. W. (2016). Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). Cardiovascular diagnosis and therapy, 6(5), 424-431. https://doi.org/10.21037/cdt.2016.03.11
Doyle, Mark, et al. "Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)." Cardiovascular diagnosis and therapy vol. 6,5 (2016): 424-431. doi: https://doi.org/10.21037/cdt.2016.03.11
Doyle M, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, Rogers WJ, Sharaf BL, Pepine CJ, Thompson DV, Rayarao G, Tauxe L, Kelsey SF, Biederman RW. Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). Cardiovasc Diagn Ther. 2016 Oct;6(5):424-431. doi: 10.21037/cdt.2016.03.11. PMID: 27747165; PMCID: PMC5059395.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 26 entries